We conclude that both down- and up-regulation of FOXO1 activity negatively influence the survival and proliferation of BL, indicating that, similar to BCP-ALL [21], FOXO1 acts as a rheostat in the oncogenic program of this utmost aggressive lymphoma. Here, FOXO1 is linked to lymphoma.